Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relx (RELX) Current Deferred Revenue (2017 - 2025)

On a quarterly basis, Current Deferred Revenue rose 6.4% to $3.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 billion, a 6.4% increase, with the full-year FY2025 number at $3.2 billion, up 6.4% from a year prior.

Relx (RELX) has 9 years of Current Deferred Revenue data on record, last reported at $3.2 billion in Q4 2025.

  • Current Deferred Revenue reached $3.2 billion in Q4 2025 per RELX's latest filing, up from $3.0 billion in the prior quarter.
  • Over the last five years, Current Deferred Revenue for RELX hit a ceiling of $3.2 billion in Q4 2025 and a floor of $2.6 billion in Q4 2021.
  • A 5-year average of $2.9 billion and a median of $2.9 billion in 2023 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: increased 2.61% in 2021, then rose 6.4% in 2025.
  • Tracing RELX's Current Deferred Revenue over 5 years: stood at $2.6 billion in 2021, then rose by 5.34% to $2.8 billion in 2022, then rose by 2.64% to $2.9 billion in 2023, then rose by 4.81% to $3.0 billion in 2024, then rose by 6.4% to $3.2 billion in 2025.
  • Business Quant data shows Current Deferred Revenue for RELX at $3.2 billion in Q4 2025, $3.0 billion in Q4 2024, and $2.9 billion in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Relx 81.40 Bn 81.16 Bn -
2 Rentokil Initial 79.56 Bn 78.10 Bn -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.18 Bn
Dec 31, 2024 2.99 Bn
Dec 31, 2023 2.85 Bn
Dec 31, 2022 2.78 Bn
Dec 31, 2021 2.64 Bn
Dec 31, 2020 2.57 Bn
Dec 31, 2019 2.66 Bn
Dec 31, 2018 2.57 Bn
Dec 31, 2017 2.54 Bn